USD10
ELDN Shares
About Eledon PharmaceuticalsEledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

USD10
ELDN Shares
About Eledon PharmaceuticalsEledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Stats

TRADING WINDOW

Closed

OPENS AT

Not enough data

MARKET CAP

$305.01M

OPEN PRICE

$3.85

LOW (1Y)

$1.35

HIGH (1Y)

$4.60

LOW (24H)

$3.83

HIGH (24H)

$4.09

VOLUME (24H)

$787.62K

3.82%

Price history

Time
Price
Change
Today
$3.85
2.64%
1 Day
$3.87
2.11%
1 Week
$4.08
3.15%
1 Month
$3.71
6.53%
1 Year
$3.69
7.09%
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.